Myelofibrosis Treatment News and Information

What is Myelofibrosis? (Definition)

According to the U.S. National Library of Medicine, Myelofibrosis is a disorder of the bone marrow in which the marrow is replaced by fibrous scar tissue. When the bone marrow is scarred, it cannot make enough blood cells. Anemia, bleeding problems, and a higher risk for infections may occur.

As a result, the liver and spleen try to make some of these blood cells. This causes these organs to swell.

Signs and Symptoms of Myelofibrosis:

Symptoms may include any of the following:

  • Abdominal fullness, pain, or feeling full before finishing a meal (because of an enlarged spleen)
  • Bone pain
  • Easy bleeding, bruising
  • Fatigue
  • Increased likelihood of getting an infection
  • Pale skin
  • Shortness of breath with exercise

See below for updated news and information regarding Myelofibrosis including new medical research, treatment options and advancements. 

Latest Myelofibrosis Treatment News and Research

Myelofibrosis Research: New data shed light on potential advantages of pacritinib for patients with myelofibrosis

(SOURCE: AMERICAN SOCIETY OF HEMATOLOGY) - Pacritinib, currently on hold by the FDA, appears to be more effective in reducing spleen volume; twice-daily dose improves symptoms. This analysis comes from data before the clinical hold. Compared with standard therapy, pacritinib significantly reduces spleen size among people with myelofibrosis who have very low levels of platelets, according to a late-breaking study being presented today ...
Read More

Myelofibrosis Advancements: Researchers Successfully Use MRI to Identify Bone Marrow Cancer

(BOSTON UNIVERSITY MEDICAL CENTER) For the first time, researchers have shown that using Magnetic Resonance Imaging (MRI) can effectively identify bone marrow cancer (myelofibrosis) in an experimental model, according to a recent press release ...
Read More